The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Public Health
(Mar 2022)
Corrigendum: Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019
Anna Maisa,
Christian Kollan,
Matthias an der Heiden,
Florian van Bömmel,
Markus Cornberg,
Stefan Mauss,
Heiner Wedemeyer,
Daniel Schmidt,
Daniel Schmidt,
Sandra Dudareva
Affiliations
Anna Maisa
Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Christian Kollan
Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Matthias an der Heiden
Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Florian van Bömmel
Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany
Markus Cornberg
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
Stefan Mauss
Center for HIV and Hepatogastroenterology, Düsseldorf, Germany
Heiner Wedemeyer
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
Daniel Schmidt
Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
Daniel Schmidt
Charité Universitätsmedizin Berlin, Berlin, Germany
Sandra Dudareva
Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
DOI
https://doi.org/10.3389/fpubh.2022.860836
Journal volume & issue
Vol. 10
Abstract
Read online
No abstracts available.
Keywords
hepatitis B
nucleos(t)ide therapy
therapy costs
treatment guidelines
treatment gap
hepatitis elimination
WeChat QR code
Close